Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Women with PCOS are more likely to experience depressive symptoms.

Depression is more common in infertile women with PCOS than those without.

Women with PCOS in Bangladesh face significant mental health issues, especially in rural areas.

Melatonin improves cashmere goat hair growth and quality by increasing antioxidants and reducing cell death.

Iron chloride helps create compounds that could be useful in medicine, like treating hair loss.

Stem cell treatment improved hair density in female hair loss patient.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

CD98hc's role in skin health decreases with age.

People with polycystic ovary syndrome often experience anxiety and depression.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Women with PCOS, especially with hirsutism, should be screened for depression and anxiety.

Women with PCOS often have depression and anxiety, so they should be checked for these issues.

Hair loss requires customized treatments based on its various causes and types.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Many women with PCOS in Saudi Arabia suffer from depression and anxiety.

PCOS significantly affects women's mental health, and more research is needed to develop effective treatments for these issues.

Lower adiponectin levels may relate to depression in women with PCOS.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.